GAMMA Investing’s Health Catalyst HCAT Stock Holding History

GAMMA Investing’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-307	Closed	-$390	–	4186
2026 Q1	$390	Sell	307 -40	-12%	-$75	﹤0.01%	3986
2025 Q4	$829	Buy	+347	New	+$949	﹤0.01%	3833
2025 Q2	–	Sell	-169	Closed	-$766	–	3830
2025 Q1	$766	Sell	169 -61	-27%	-$323	﹤0.01%	3610
2024 Q4	$1.63K	Buy	230 +165	+254%	+$1.31K	﹤0.01%	3285
2024 Q3	$529	Sell	65 -7	-10%	-$51	﹤0.01%	3385
2024 Q2	$460	Buy	+72	New	+$462	﹤0.01%	3222

Other funds holding HCAT

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

SRS

Strong Retirement Solutions Silverdale, Washington $167M AUM

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

GAMMA Investing's HCAT Position: Q2 2026 in Review

GAMMA Investing sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 307 shares — an estimated $390 sold.

GAMMA Investing first reported a position in HCAT in Q2 2024 and held it in 6 quarters. The position peaked at $1.63K in Q4 2024. 13 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

GAMMA Investing reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 307 Health Catalyst shares in Q2 2026, an estimated $390.
GAMMA Investing first reported a position in Health Catalyst in Q2 2024 and held it in 6 quarters.
GAMMA Investing's Health Catalyst position peaked at $1.63K in Q4 2024.
13 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.